{"gao_id": "GAO-18-40", "published": "2017-11-17T12:00:00Z", "released": "2017-12-19T07:00:00Z", "summary": "The amount of money people spend on prescription drugs has nearly doubled since the 1990s. Much of this increase is due to expensive brand-name drugs, but the prices of some generics have also gone up. We looked into changes in the drug industry and found that pharmaceutical and biotechnology sales revenue increased from $534 billion to $775 billion between 2006 and 2015. Additionally, 67% of...", "title": "Drug Industry: Profits, Research and Development Spending, and Merger and Acquisition Deals", "topics": ["Biologics", "Prescription drugs", "Pharmaceutical industry", "Corporate mergers", "Drugs", "Mergers and acquisitions", "Biotechnology", "Research and development", "Drug approvals", "Orphan drugs", "Business Regulation and Consumer Protection", "Clinical trials", "Pharmacological research"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-18-40", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-18-40-highlights.pdf"}, {"title": "Full Report (78 pages)", "url": "https://www.gao.gov/assets/gao-18-40.pdf"}, {"title": "Accessible PDF (90 pages)", "url": "https://www.gao.gov/assets/690/689292.pdf"}]}